Supplementary Figure 1 from A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study
Year: 2023
Type: supplementary-materials
Abstract: Mean plasma concentration vs. time curve at belinostat 250 mg/m2.
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361920405